| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10037378 | EAAAYSSGGGAAGAGLAGR | 133 | ||
| 10040843 | S | 339 | ||
| 10040844 | S | 406 | ||
| 10041359 | S | 344 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10037378 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | None | 30620550 | Peptide quantification value was applied to each modification site | |
| 10040843 | MS | HTP | unambiguous | human | PANC-1 cells | None | 39531497 | |||
| 10040844 | MS | HTP | unambiguous | human | PANC-1 cells | None | 39531497 | |||
| 10041359 | MS | HTP | unambiguous | human | PANC-1 cells | None | 39531497 |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10037378 | EAAAYSSGGGAAGAGLAGR | 133 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10040843 | S | 339 | MS | HTP | unambiguous | human | PANC-1 cells | 39531497 | |||
| 10040844 | S | 406 | MS | HTP | unambiguous | human | PANC-1 cells | 39531497 | |||
| 10041359 | S | 344 | MS | HTP | unambiguous | human | PANC-1 cells | 39531497 |